Delivery Order SPE2DB22D9112-SPE2DB25FTKPC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,151.64 to DMS Pharmaceutical Group Inc. for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed in Park Ridge, Illinois, the vendor's headquarters location. DMS Pharmaceutical Group Inc., a woman-owned...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $94,236.00 to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of Menveo 1 vial (meningococcal vaccine, groups A, C, Y, and W-135) in 0.5mL dosage form. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, was issued without a set-aside designation. The order will be fulfilled from DMS Pharmaceutical Group's location in Park Ridge, Illinois, and represents a component of the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,535.52 to DMS Pharmaceutical Group Inc. for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, operates under firm fixed-price terms with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,441.24 by the Defense Logistics Agency on July 30, 2025. The delivery order is for MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product, with an ultimate completion date of July 31, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal...
- The Defense Logistics Agency awarded a $2,195.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 8, 2025, with an ultimate completion date of August 11, 2025. The delivery order covers Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, to be delivered to Conshohocken, Pennsylvania. This award carries no set-aside designation and represents a discrete delivery order issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,947.96 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine. The contract, which carries an ultimate completion date of August 15, 2025, was issued without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $8,647.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MENVEO A-C-Y-W Kit (2 Vials). The award was issued on May 8, 2025, with an ultimate completion date of May 9, 2025, and does not include any set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- This is a $1,080.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the MENVEO VACCINE VL 5S medical product, with an ultimate completion date of June 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,522.17 for MENVEO Vaccine VL 5S under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program. The award is firm fixed price with no set-aside designation, and the ultimate completion date is July 31, 2025. This delivery order represents one of numerous pharmaceutical product orders issued under DMS Pharmaceutical...
- Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a $6,236.64 firm fixed price delivery order to supply one vial of MENVEO, a meningococcal vaccine. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide various pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKPCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,801.55 to DMS Pharmaceutical Group Inc. for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, was executed without a set-aside designation. The award represents a standard transactional order under DMS Pharmaceutical Group's broader pharmaceutical supply contract with DLA, fulfilling the agency's ongoing need for vaccines and immunological products to support military and federal healthcare facilities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. This delivery order falls under that IDC framework, which authorizes DLA to procure an extensive range of pharmaceutical products including prescription medications, biologics, vaccines, and medical consumables. The company's established position as a critical supplier in the federal pharmaceutical supply chain enables it to provide direct distribution of pharmacy products to Department of Defense healthcare sites nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/24/25 |